Steven Perrin

Steven Perrin

Fortune : 3 810 $ au 31/05/2026

61 ans
Health Technology
Consumer Services
Commercial Services

Profil

Steven N.
Perrin
is the founder of Anelixis Therapeutics, Inc., founded in 2013, where the titles held included President, CEO, Treasurer & Director.
Current jobs include Executive Chairman at ALS Therapy Development Foundation, Inc. since 2018 (job started in 2007) and President, Chief Scientific Officer & Director at Eledon Pharmaceuticals, Inc. since 2020.
Former jobs include Associate Director-Molecular Profiling at Biogen, Inc. from 2001 to 2006, Scientist at Biogen MA, Inc., ARIAD Pharmaceuticals, Inc., and Aventis Pharmaceuticals, Inc., Assistant Professor at Boston University, Principal at Hoechst Ariad Genomics Center Llc, and Associate Professor at Boston University School of Medicine.
Education includes an undergraduate degree from Boston College in 1987 and a doctorate from Boston University School of Medicine in 1994.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 1 000 ( 0% ) 3 810 $ 31/05/2026

Postes actifs de Steven Perrin

SociétésPosteDébut
ELEDON PHARMACEUTICALS, INC. President 14/09/2020
Président 01/06/2010

Anciens postes connus de Steven Perrin

SociétésPosteFin
BIOGEN INC. Corporate Officer/Principal 01/12/2006
Corporate Officer/Principal -
Fondateur -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Steven Perrin

Formation de Steven Perrin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

85

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Steven Perrin
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT